France Insulin Patch Pumps Market Size & Outlook, 2023-2030
The insulin patch pumps market in France is expected to reach a projected revenue of US$ 69.9 million by 2030. A compound annual growth rate of 10.8% is expected of France insulin patch pumps market from 2024 to 2030.
The France insulin patch pumps market generated a revenue of USD 34.0 million in 2023 and is expected to reach USD 69.9 million by 2030.
The France market is expected to grow at a CAGR of 10.8% from 2024 to 2030.
In terms of segment, basal and bolus was the largest revenue generating delviery mode in 2023.
Basal and Bolus is the most lucrative delviery mode segment registering the fastest growth during the forecast period.
Insulin patch pumps market data book summary
Market revenue in 2023
USD 34.0 million
Market revenue in 2030
USD 69.9 million
Growth rate
10.8% (CAGR from 2023 to 2030)
Largest segment
Basal and bolus
Fastest growing segment
Basal and Bolus
Historical data
2018 - 2022
Base year
2023
Forecast period
2024 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Basal, Bolus, Basal and Bolus
Key market players worldwide
Medtronic PLC, Roche Holding AG, Insulet Corp, Terumo Corp, Tandem Diabetes Care Inc, CeQur Simplicity, Medtrum, Debiotech
Other key industry trends
In terms of revenue, France accounted for 3.4% of the global insulin patch pumps market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Europe, Germany insulin patch pumps market is projected to lead the regional market in terms of revenue in 2030.
Germany is the fastest growing regional market in Europe and is projected to reach USD 108.3 million by 2030.
France’s insulin pump market is driven by the increasing prevalence of diabetes, rapid technological advancements, and the availability of reimbursement & supportive health insurance policies. Furthermore, the local presence of several market leaders and their innovative product launches in the diabetes care space are expected to drive the market over the coming years.
In 2016, Diabeloop, a France-based company, secured regulatory approval for its artificial pancreas system in Europe. This was the first artificial pancreas system and also the first regulatory-approved system using Dexcom CGM.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Insulin Patch Pumps Market Outlook will help companies and investors design strategic landscapes.
Basal And Bolus was the largest segment with a revenue share of 56.47% in 2023.
Horizon Databook has segmented the France insulin patch pumps market based on basal, bolus, basal and bolus covering the revenue growth of each sub-segment from 2018 to 2030.
France’s insulin pump market is driven by the increasing prevalence of diabetes, rapid technological advancements, and the availability of reimbursement & supportive health insurance policies. Furthermore, the local presence of several market leaders and their innovative product launches in the diabetes care space are expected to drive the market over the coming years.
In 2016, Diabeloop, a France-based company, secured regulatory approval for its artificial pancreas system in Europe. This was the first artificial pancreas system and also the first regulatory-approved system using Dexcom CGM.
France Insulin Patch Pumps Market Delviery Mode Outlook (Revenue, USD Million , 2018-2030)
Basal
Bolus
Basal and Bolus
France Insulin Patch Pumps Market Type Outlook (Revenue, USD Million , 2018-2030)
Disposable
Reusable
France Insulin Patch Pumps Market Distribution Channel Outlook (Revenue, USD Million , 2018-2030)
Hospitals
Retail Pharmacies
Private Clinics
Online Pharmacies
Others
Reasons to subscribe to Insulin Patch Pumps Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Insulin Patch Pumps Market Outlook databook
Our clientele includes a mix of Insulin Patch Pumps Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France Insulin Patch Pumps Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into France Insulin Patch Pumps Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
France Insulin Patch Pumps Market, 2018-2030 (US$M)